EP4 and EP2 receptor subtypes involved in colonic secretion in rat

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

EP4 and EP2 receptor subtypes involved in colonic secretion in rat. / Mosa, A.S.; Hansen, M.B.; Tilotta, C.M.; Bindslev, N.

In: Basic & Clinical Pharmacology & Toxicology, Vol. 103, No. 3, 2008, p. 214-221.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Mosa, AS, Hansen, MB, Tilotta, CM & Bindslev, N 2008, 'EP4 and EP2 receptor subtypes involved in colonic secretion in rat', Basic & Clinical Pharmacology & Toxicology, vol. 103, no. 3, pp. 214-221.

APA

Mosa, A. S., Hansen, M. B., Tilotta, C. M., & Bindslev, N. (2008). EP4 and EP2 receptor subtypes involved in colonic secretion in rat. Basic & Clinical Pharmacology & Toxicology, 103(3), 214-221.

Vancouver

Mosa AS, Hansen MB, Tilotta CM, Bindslev N. EP4 and EP2 receptor subtypes involved in colonic secretion in rat. Basic & Clinical Pharmacology & Toxicology. 2008;103(3):214-221.

Author

Mosa, A.S. ; Hansen, M.B. ; Tilotta, C.M. ; Bindslev, N. / EP4 and EP2 receptor subtypes involved in colonic secretion in rat. In: Basic & Clinical Pharmacology & Toxicology. 2008 ; Vol. 103, No. 3. pp. 214-221.

Bibtex

@article{4232f0b0f77211ddbf70000ea68e967b,
title = "EP4 and EP2 receptor subtypes involved in colonic secretion in rat",
abstract = "The study was designed to determine the prostaglandin EP receptor subtypes functionally involved in electrogenic ion secretion in rat colon. With 30 rats, measurements of short circuit current (SCC) and slope conductance were obtained by Ussing chamber technique. Prostaglandin E2 (PGE(2)) and other EP receptor selective agonists were employed on stripped rat colon pre-treated with indomethacin and theophylline. Receptor-specific agonists were butaprost (EP2), sulprostone (EP1 and EP3) and PGE(1) alcohol (OH-PGE(1)) (EP4). GW627368X was used as a specific EP4 receptor antagonist. Forskolin-induced SCC was used as a control of tissue viability. The mean basal SCC was 24.5 +/- 0.9 mu A/cm(2) (range 9.8-45.1), and mean basal slope conductance was 23.7 +/- 6.1 mS/cm(2) (range 9.7-39.8). The basal SCC decreased after pre-treatment with indomethacin and increased after pre-treatment with theophylline. PGE(2), butaprost and OH-PGE(1) stimulated maximal increase in SCC (55.8 +/- 4.1, 43.9 +/- 3.8 and 93.9 +/- 2.7 mu A/cm(2), respectively), while sulprostone had no apparent effects. GW627368X eliminated OH-PGE(1)-induced SCC and partially PGE(2)-induced SCC, leaving butaprost-induced SCC almost unperturbed. Bumetanide, 20 mu M, inhibited between 40% and 80% of the agonist-induced changes in SCC. In conclusion, compilation of the results on induced SCC by subtype specific receptor agonists for EP receptors and the pattern of induced SCCs inhibited by GW627368X indicate the EP4 receptor subtype as the major mediator of PGE(2)-induced electrogenic ion secretion with a lesser induction through the EP2 receptor subtype Udgivelsesdato: 2008/9",
author = "A.S. Mosa and M.B. Hansen and C.M. Tilotta and N. Bindslev",
note = "Times Cited: 0ArticleEnglishBindslev, NUniv Copenhagen, Dept Biomed Sci, Panum Bldg, DK-2200 Copenhagen NV, DenmarkCited References Count: 49337YVBLACKWELL PUBLISHING9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLANDOXFORD",
year = "2008",
language = "English",
volume = "103",
pages = "214--221",
journal = "Basic and Clinical Pharmacology and Toxicology",
issn = "1742-7835",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - EP4 and EP2 receptor subtypes involved in colonic secretion in rat

AU - Mosa, A.S.

AU - Hansen, M.B.

AU - Tilotta, C.M.

AU - Bindslev, N.

N1 - Times Cited: 0ArticleEnglishBindslev, NUniv Copenhagen, Dept Biomed Sci, Panum Bldg, DK-2200 Copenhagen NV, DenmarkCited References Count: 49337YVBLACKWELL PUBLISHING9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLANDOXFORD

PY - 2008

Y1 - 2008

N2 - The study was designed to determine the prostaglandin EP receptor subtypes functionally involved in electrogenic ion secretion in rat colon. With 30 rats, measurements of short circuit current (SCC) and slope conductance were obtained by Ussing chamber technique. Prostaglandin E2 (PGE(2)) and other EP receptor selective agonists were employed on stripped rat colon pre-treated with indomethacin and theophylline. Receptor-specific agonists were butaprost (EP2), sulprostone (EP1 and EP3) and PGE(1) alcohol (OH-PGE(1)) (EP4). GW627368X was used as a specific EP4 receptor antagonist. Forskolin-induced SCC was used as a control of tissue viability. The mean basal SCC was 24.5 +/- 0.9 mu A/cm(2) (range 9.8-45.1), and mean basal slope conductance was 23.7 +/- 6.1 mS/cm(2) (range 9.7-39.8). The basal SCC decreased after pre-treatment with indomethacin and increased after pre-treatment with theophylline. PGE(2), butaprost and OH-PGE(1) stimulated maximal increase in SCC (55.8 +/- 4.1, 43.9 +/- 3.8 and 93.9 +/- 2.7 mu A/cm(2), respectively), while sulprostone had no apparent effects. GW627368X eliminated OH-PGE(1)-induced SCC and partially PGE(2)-induced SCC, leaving butaprost-induced SCC almost unperturbed. Bumetanide, 20 mu M, inhibited between 40% and 80% of the agonist-induced changes in SCC. In conclusion, compilation of the results on induced SCC by subtype specific receptor agonists for EP receptors and the pattern of induced SCCs inhibited by GW627368X indicate the EP4 receptor subtype as the major mediator of PGE(2)-induced electrogenic ion secretion with a lesser induction through the EP2 receptor subtype Udgivelsesdato: 2008/9

AB - The study was designed to determine the prostaglandin EP receptor subtypes functionally involved in electrogenic ion secretion in rat colon. With 30 rats, measurements of short circuit current (SCC) and slope conductance were obtained by Ussing chamber technique. Prostaglandin E2 (PGE(2)) and other EP receptor selective agonists were employed on stripped rat colon pre-treated with indomethacin and theophylline. Receptor-specific agonists were butaprost (EP2), sulprostone (EP1 and EP3) and PGE(1) alcohol (OH-PGE(1)) (EP4). GW627368X was used as a specific EP4 receptor antagonist. Forskolin-induced SCC was used as a control of tissue viability. The mean basal SCC was 24.5 +/- 0.9 mu A/cm(2) (range 9.8-45.1), and mean basal slope conductance was 23.7 +/- 6.1 mS/cm(2) (range 9.7-39.8). The basal SCC decreased after pre-treatment with indomethacin and increased after pre-treatment with theophylline. PGE(2), butaprost and OH-PGE(1) stimulated maximal increase in SCC (55.8 +/- 4.1, 43.9 +/- 3.8 and 93.9 +/- 2.7 mu A/cm(2), respectively), while sulprostone had no apparent effects. GW627368X eliminated OH-PGE(1)-induced SCC and partially PGE(2)-induced SCC, leaving butaprost-induced SCC almost unperturbed. Bumetanide, 20 mu M, inhibited between 40% and 80% of the agonist-induced changes in SCC. In conclusion, compilation of the results on induced SCC by subtype specific receptor agonists for EP receptors and the pattern of induced SCCs inhibited by GW627368X indicate the EP4 receptor subtype as the major mediator of PGE(2)-induced electrogenic ion secretion with a lesser induction through the EP2 receptor subtype Udgivelsesdato: 2008/9

M3 - Journal article

VL - 103

SP - 214

EP - 221

JO - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

SN - 1742-7835

IS - 3

ER -

ID: 10248624